计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab169321-100μg |
100μg |
现货 ![]() |
| |
| Ab169321-1mg |
1mg |
现货 ![]() |
| |
| Ab169321-5mg |
5mg |
现货 ![]() |
| |
| Ab169321-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Relatlimab (anti-LAG-3/CD223), LAG3 (CD223) 抗体 |
|---|---|
| 别名 | 瑞拉利单抗 |
| 英文别名 | BMS-986016 | RELA | CD223 antibody | CD223 antigen antibody | FDC protein antibody | LAG-3 antibody | Lag3 antibody | LAG3_HUMAN antibody | Lymphocyte activating 3 antibody | Lymphocyte activation gene 3 antibody | Lymphocyte activation gene 3 protein ant |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | LAG3/CD223 |
| 应用 | Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 作用类型 | 抑制剂 |
| 作用机制 | LAG3 (CD223) 抗体 |
| 抗体类型 | Primary antibody |
|---|---|
| 克隆类型 | 重组抗体 |
| Format | Whole IgG |
| 亚型 | Human IgG4SP |
| 轻链亚型 | kappa |
| SDS-PAGE | 27.1 kDa (Light Chain) & 53.4 kDa (Heavy Chain), under reducing conditions; 176.6 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 来源 | CHO supernatant |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1673516-98-7 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Relatlimab (anti-LAG-3/CD223) (Ab169321) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood mononuclear lymphocytes labelling LAG-3/CD223 (red) with Relatlimab (anti- LAG-3/CD223) (Ab169321). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Relatlimab (anti-LAG-3/CD223) (Ab169321) - SEC
The purity of Relatlimab (anti-LAG-3/CD223) (Ab169321) is more than 95% verified by HPLC.
Relatlimab (anti-LAG-3/CD223) (Ab169321) - ELISA
Immobilized Recombinant Human LAG-3 protein (rp176292) at 1.0 μg/mL can bind Relatlimab (anti-LAG-3/CD223) (Ab169321) with the EC₅₀ of 41.53 ng/mL.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab169321 | |
| 分析证书 | Ab169321 | |
| 分析证书 | Ab169321 | |
| 分析证书 | Ab169321 | |
| 分析证书 | Ab169321 |
¥669.90
¥609.90
¥579.90
¥519.90
¥899.90
¥609.90
| 1. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI et al.. (2004) Role of LAG-3 in regulatory T cells.. Immunity, 21 (4): (503-13). [PMID:15485628] |
| 2. Nguyen LT, Ohashi PS. (2015) Clinical blockade of PD1 and LAG3--potential mechanisms of action.. Nat Rev Immunol, 15 (1): (45-56). [PMID:25534622] |
| 3. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E, Hercend T. (1990) LAG-3, a novel lymphocyte activation gene closely related to CD4.. J Exp Med, 171 (5): (1393-405). [PMID:1692078] |
| 4. Baixeras, E E and 8 more authors.. (1992) Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.. The Journal of experimental medicine, (1): [PMID:1380059] |
| 5. Huard, B B and 8 more authors.. (1997) Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.. Proceedings of the National Academy of Sciences of the United States of America, (27): [PMID:9159144] |
| 6. Bruniquel, D D, Borie, N N, Hannier, S S and Triebel, F F.. (1998) Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.. Immunogenetics, [PMID:9634475] |
| 7. Scherer, Steven E SE and 216 more authors.. (2006) The finished DNA sequence of human chromosome 12.. Nature, (16): [PMID:16541075] |
| 8. Camisaschi, Chiara C and 9 more authors.. (2010) LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:20421648] |
| 9. Wang, Jun and 20 more authors.. (2019) Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.. Cell, (10): [PMID:30580966] |